Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.
Khatri VM, Mestres-Villanueva MA, Yarlagadda S, Doniparthi A, Smith DB, Nakashima JY, Bryant JM, Zhao D, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Williams NO, Mahtani RL, Ahluwalia MS, Soliman HH, Han HS, Soyano AE, Kim Y, Kotecha R, Beyer SJ, Ahmed KA.
Khatri VM, et al. Among authors: han hs.
NPJ Breast Cancer. 2024 Nov 21;10(1):100. doi: 10.1038/s41523-024-00711-w.
NPJ Breast Cancer. 2024.
PMID: 39572568
Free article.